Nanjing Hicin Pharmaceutical Co Ltd (300584) - Cash Flow Conversion Efficiency

Latest as of September 2025: -0.007x

Based on the latest financial reports, Nanjing Hicin Pharmaceutical Co Ltd (300584) has a cash flow conversion efficiency ratio of -0.007x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥-7.15 Million ≈ $-1.05 Million USD) by net assets (CN¥1.07 Billion ≈ $157.05 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see how much is Nanjing Hicin Pharmaceutical Co Ltd worth for the company's overall valuation and market capitalisation.

Nanjing Hicin Pharmaceutical Co Ltd - Cash Flow Conversion Efficiency Trend (2012–2025)

This chart illustrates how Nanjing Hicin Pharmaceutical Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. View 300584 stock price and chart for real-time trading data and today's change.

Nanjing Hicin Pharmaceutical Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Nanjing Hicin Pharmaceutical Co Ltd ranked by their cash flow conversion efficiency. Review 300584 cash flow after capex ratio to assess how much free cash flow the company generates relative to operating cash flow.

Company	Cash Flow Conversion Efficiency
SEC Electric Mach Co Ltd SHG:603988	0.015x
Cytek Biosciences Inc NASDAQ:CTKB	-0.008x
Shandong Molong Petroleum Machinery Co Ltd SHE:002490	-0.063x
Shanghai Sinotec Co Ltd SHG:603121	0.048x
Tera Yatirim Menkul Degerler A.S. IS:TERA	-0.394x
Mystate Ltd AU:MYS	0.140x
Chong Kun Dang Pharmaceutical KO:185750	0.012x
Hartadinata Abadi Tbk PT JK:HRTA	-0.477x

Annual Cash Flow Conversion Efficiency for Nanjing Hicin Pharmaceutical Co Ltd (2012–2025)

The table below shows the annual cash flow conversion efficiency of Nanjing Hicin Pharmaceutical Co Ltd from 2012 to 2025. Also see 300584 total assets for a full breakdown of the balance sheet.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	CN¥1.10 Billion ≈ $160.94 Million	CN¥78.09 Million ≈ $11.43 Million	0.071x	+22.93%
2024-12-31	CN¥1.04 Billion ≈ $151.92 Million	CN¥59.96 Million ≈ $8.77 Million	0.058x	+138.31%
2023-12-31	CN¥987.50 Million ≈ $144.50 Million	CN¥23.93 Million ≈ $3.50 Million	0.024x	+495.88%
2022-12-31	CN¥950.57 Million ≈ $139.10 Million	CN¥-5.82 Million ≈ $-851.55K	-0.006x	-109.69%
2021-12-31	CN¥948.48 Million ≈ $138.79 Million	CN¥59.94 Million ≈ $8.77 Million	0.063x	-41.53%
2020-12-31	CN¥678.97 Million ≈ $99.35 Million	CN¥73.39 Million ≈ $10.74 Million	0.108x	-27.33%
2019-12-31	CN¥653.98 Million ≈ $95.70 Million	CN¥97.28 Million ≈ $14.23 Million	0.149x	+11.91%
2018-12-31	CN¥580.93 Million ≈ $85.01 Million	CN¥77.21 Million ≈ $11.30 Million	0.133x	+47.79%
2017-12-31	CN¥517.68 Million ≈ $75.75 Million	CN¥46.56 Million ≈ $6.81 Million	0.090x	-34.20%
2016-12-31	CN¥276.11 Million ≈ $40.40 Million	CN¥37.74 Million ≈ $5.52 Million	0.137x	-40.39%
2015-12-31	CN¥235.08 Million ≈ $34.40 Million	CN¥53.90 Million ≈ $7.89 Million	0.229x	+88.91%
2014-12-31	CN¥200.15 Million ≈ $29.29 Million	CN¥24.29 Million ≈ $3.55 Million	0.121x	-55.41%
2013-12-31	CN¥165.93 Million ≈ $24.28 Million	CN¥45.16 Million ≈ $6.61 Million	0.272x	-6.87%
2012-12-31	CN¥132.65 Million ≈ $19.41 Million	CN¥38.77 Million ≈ $5.67 Million	0.292x	--

About Nanjing Hicin Pharmaceutical Co Ltd

SHE:300584 China Drug Manufacturers - Specialty & Generic

Market Cap

$588.60 Million

CN¥4.02 Billion CNY

Market Cap Rank

#11439 Global

#3257 in China

Share Price

CN¥33.52

Change (1 day)

-0.83%

52-Week Range

CN¥29.01 - CN¥71.90

All Time High

CN¥83.16